Phagenesis has successfully reached the first of two milestones in its staged acquisition agreement with Nestlé Health Science
Manchester, 4 October 2017 – Phagenesis announced today that by completing a key clinical study in Europe it has reached the first milestone in its staged acquisition agreement with Nestlé Health Science (NHSc). Under the terms of the agreement, Nestlé … Continue reading